AUROPHARMA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.2

📈 Bullish momentum supported by strong RSI and MACD signals.

💡 Optimal Buy Price: ₹1,145

🎯 Profit Target: ₹1,175 | Stop Loss: ₹1,135

⏱️ If already holding, consider exiting near ₹1,175 or if price dips below ₹1,135 with rising volume.

📈 Positive

• 📊 Quarterly profit surged 69.9% (₹559 Cr. vs ₹408 Cr.)
• 📈 RSI at 63.1 indicates strong buying momentum
• 📉 MACD at 11.2 confirms bullish crossover
• 📍 Current price above both DMA 50 and DMA 200 (₹1,103 & ₹1,139)
• 💰 EPS of ₹33.7 and book value of ₹350 ₹

⚠️ Limitation

• 🔇 Volume (10.7L) is below 1-week average (20.8L)
• 📉 PEG ratio of 8.00 suggests overvaluation
• 📉 Slight decline in FII holding (-0.17%)

🚫 Company Negative News

• 📉 Stock has declined 13.2% YTD and 17.68% in 1 year

  TradingView

✅ Company Positive News

• 📅 Upcoming earnings report expected in 2 days with EPS estimate of ₹15.24

  TradingView

• 📈 TSR strength index ranks AUROPHARMA as more bullish than 84.26% of stocks

  TSR

🏭 Industry

• 🧪 Operates in the pharmaceuticals sector with Industry PE of 33.1
• 📊 AUROPHARMA trades at a slightly higher PE of 34.2, indicating investor optimism

🧾 Conclusion

• AUROPHARMA is a strong candidate for intraday trading based on technical indicators
• Momentum favors bullish trades with tight stop-loss strategy
• Watch for volume confirmation and earnings-related volatility

Sources

TradingView

+2

Would you like me to chart AUROPHARMA’s intraday support and resistance zones or compare it with another pharma stock?